What’s Developing in Alzheimer’s Disease Treatment?

Lawrence Friedhoff, MD PhD Alzheimer’s researcher Guest article by Lawrence Friedhoff, MD, PhD My work in Alzheimer’s disease therapeutics began about 20 years ago. After completing my medical training, I was interested in exploring another side of medicine—how new drugs are developed. Attitudes toward dementia have changed drastically over the past two decades. Back then, the term Alzheimer’s disease wasn’t widely used, nor was it viewed as a credible illness. Instead, people referred to the symptoms of Alzheimer’s as “senile dementia,” an inevitable consequence of aging that was considered untreatable. In the early 1990s, I began working for a […]